A Chat with Bernie Iliakis of CorneaGen - Scorecard - MDSpire

A Chat with Bernie Iliakis of CorneaGen

Bernie Iliakis, president and CEO of CorneaGen, discusses the growing momentum of CTAK to treat keratoconus, how the company is meeting the growing demand for DMEK and DSAEK tissue processing, and more.

  • November 1, 2025

  • 4 min

Share

Clinical Scorecard: A Chat with Bernie Iliakis of CorneaGen

At a Glance

CategoryDetail
Condition
Key MechanismsCTAK utilizes custom tissue inlays for contouring keratoconic eyes, significantly improving visual acuity.
Target Population
Care Setting

Key Highlights

  • clinical_trials

Guideline-Based Recommendations

Diagnosis

    Management

    • Utilize CTAK for surgical intervention in keratoconus patients.
    • Consider other management options such as corneal cross-linking or traditional grafting techniques.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Individuals diagnosed with keratoconus.

        CTAK provides a tailored approach to corneal grafting, enhancing surgical outcomes.

        Clinical Best Practices

        • Employ custom tissue inlays for improved surgical precision.
        • Utilize preloaded DSAEK and DMEK tissue to save OR time and enhance tissue quality, as highlighted in the context.

        References

        Original Source(s)

        A Chat with Bernie Iliakis of CorneaGen

        • November 1, 2025

        Related Content

        Keratoconus in Hormonal Flux 

        Is it time to rethink the importance of hormonal changes on keratoconus pathology?

        • February 12, 2026

        • 3 min
        Online Photo Diagnosis: Post-Graft Alternatives to Scleral Lenses 

        Exploring the challenges and solutions for post-graft contact lens fittings, especially for corneal GP lens wearers.

        Corneal Crosslinking Reimbursement<br>In Its Tenth Year

        Providing crosslinking procedures in an ophthalmology practice is not for the faint of heart. Ultimately, despite its clinical importance, offering crosslinking remains financially challenging for many practices.